Literature DB >> 10398229

CAG repeat contraction in the androgen receptor gene in three brothers with mental retardation.

R F Kooy1, E Reyniers, K Storm, L Vits, D van Velzen, P E de Ruiter, A O Brinkmann, A de Paepe, P J Willems.   

Abstract

We report on three brothers with mental retardation and a contracted CAG repeat in the androgen receptor (AR) gene. It is known that expansion of the CAG repeat in this gene leads to spinal and bulbar muscular atrophy (SBMA or Kennedy disease); however, contracted repeats have not yet been implicated in disease. As the range of the length of CAG repeats in the AR gene, like those of other genes associated with dynamic mutations, follows a normal distribution, the theoretical possibility of disease at both ends of the distribution should be considered. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398229

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

Review 1.  Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease).

Authors:  Josef Finsterer; Gianni Soraru
Journal:  J Mol Neurosci       Date:  2015-10-19       Impact factor: 3.444

2.  Exploration of CAG triplet repeat in nontranslated region of SCA12 gene.

Authors:  Waseem Gul Lone; Imran Ali Khan; Subhadra Poornima; Noor Ahmad Shaik; Angmuthu Kanikannan Meena; Kaipa Prabhakar Rao; Qurratulain Hasan
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

Review 3.  Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.

Authors:  Marianthi Breza; Georgios Koutsis
Journal:  J Neurol       Date:  2018-07-13       Impact factor: 4.849

4.  Role of dynamic and mitochondrial mutations in neurodegenerative diseases with ataxia: lower repeats and LNAs at multiple loci as alternative pathogenesis.

Authors:  Waseem Gul Lone; Subhadra Poornima; Angmuthu Kanikannan Meena; Kaipa Prabhakar Rao; Qurratulain Hasan
Journal:  J Mol Neurosci       Date:  2014-10-12       Impact factor: 3.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.